A 4368
Alternative Names: A4368Latest Information Update: 28 Oct 2024
Price :
$50 *
At a glance
- Originator Autophagy Sciences
- Class
- Mechanism of Action Autophagy stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for phase-I development in Non-alcoholic-steatohepatitis(In volunteers) in South Korea (PO, Tablet)
- 25 Jul 2022 Autophagy completes a phase I trial in Non-alcoholic steatohepatitis (In volunteers) in South Korea (NCT04932252)
- 07 Sep 2021 Phase-I clinical trials in Non-alcoholic steatohepatitis (In volunteers) in South Korea (PO) (NCT04932252)